In her latest Industry Insights Column for eyeforpharma, President Rita Numerof, Ph.D., addresses the commercial model changes organizations need to make in adapting to the evolving healthcare delivery market.

Pharma’s delivery organization customers are adjusting to survive in a much tougher business climate we call Healthcare 2.0.   This should prompt pharma companies to reevaluate the assumptions on which they’ve built their commercial models, or they risk falling behind the curve.